A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.
Breast Cancer Res Treat
; 198(2): 217-229, 2023 Apr.
Article
in En
| MEDLINE
| ID: mdl-36735117
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Limits:
Female
/
Humans
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2023
Type:
Article
Affiliation country:
United States